Auron Therapeutics
Alexandra joined Polaris Partners in 2019 and serves as a partner in the New York office. She is primarily focused on early stage biotech and healthcare investments.
She currently serves on the Board of Directors of BeMeHealth, Podimetrics, SunBird Bio, and Trex Bio, and as a Board Observer to Engine Bio.
Alexandra received a PhD in Chemical Biology from Harvard University, where she studied natural product discovery. Alexandra performed her undergraduate studies at New York University.
This person is not in the org chart
This person is not in any offices
Auron Therapeutics
1 followers
Auron Therapeutics aims to cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to the transformation of malignant cells into more normal functioning cells.